Lectin pathway of complement activation and relation with clinical complications in critically ill children

Pediatric Research

Volumn 75, Issue 1, 2014, Pages 99-108

  Ingels, Catherine ^a   Vanhorebeek, Ilse ^a   Steffensen, Rudi ^b   Derese, Inge ^a   Jensen, Lisbeth ^c   Wouters, Pieter J ^a   Hermans, Greet ^a   Thiel, Steffen ^c   Van Den Berghe, Greet ^a  

^a LABORATORY OF MOLECULAR AND CELLULAR SIGNALING   (Belgium)

^b AALBORG UNIVERSITY HOSPITAL   (Denmark)

^c AARHUS UNIVERSITY   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

FICOLIN; MANNOSE BINDING LECTIN; MANNOSE BINDING LECTIN ASSOCIATED PROTEIN 2; MANNOSE BINDING LECTIN ASSOCIATED PROTEIN 3; MANNOSE BINDING LECTIN ASSOCIATED SERINE PROTEASE; MANNOSE BINDING LECTIN ASSOCIATED SERINE PROTEASE 1; UNCLASSIFIED DRUG;

ARTICLE; CHILD; CHILDHOOD DISEASE; COMPLEMENT ACTIVATION; COMPLEMENT LECTIN PATHWAY; CONTROLLED STUDY; CRITICAL ILLNESS; CRITICALLY ILL PATIENT; DISEASE SEVERITY; FEMALE; GENE FREQUENCY; GENETIC POLYMORPHISM; GENETIC VARIABILITY; HUMAN; INFECTIOUS COMPLICATION; INNATE IMMUNITY; INTENSIVE CARE UNIT; MAJOR CLINICAL STUDY; MALE; PRESCHOOL CHILD; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SCHOOL CHILD;

CHILD; COMPLEMENT ACTIVATION; CRITICAL ILLNESS; HUMANS; INTENSIVE CARE UNITS, PEDIATRIC; LECTINS; PATIENT ADMISSION; SERINE PROTEASES;

EID: 84893289959     PISSN: 00313998     EISSN: 15300447     Source Type: Journal    
DOI: 10.1038/pr.2013.180     Document Type: Article

References (41)

1. Vlasselaers D, Milants I, Desmet L, et al. Intensive insulin therapy for patients in paediatric intensive care: A prospective, randomised controlled study. Lancet 2009;373:547-56.
2. Robertson CM, Coopersmith CM. The systemic inflammatory response syndrome. Microbes Infect 2006;8:1382-9.
3. Kumpf O, Schumann RR. Genetic variation in innate immunity pathways and their potential contribution to the SIRS/CARS debate: Evidence from human studies and animal models. J Innate Immun 2010;2:381-94.
4. Wong HR. Genetics and genomics in pediatric septic shock. Crit Care Med 2012;40:1618-26.
5. Kumar H, Kawai T, Akira S. Pathogen recognition in the innate immune response. Biochem J 2009;420:1-16.
6. Sørensen R, Thiel S, Jensenius JC. Mannan-binding-lectin- associated serine proteases, characteristics and disease associations. Springer Semin Immunopathol 2005;27:299-319.
7. Degn SE, Hansen AG, Steffensen R, Jacobsen C, Jensenius JC, Thiel S. MAp44, a human protein associated with pattern recognition molecules of the complement system and regulating the lectin pathway of complement activation. J Immunol 2009;183:7371-8.
8. Neth O, Hann I, Turner MW, Klein NJ. Deficiency of mannose-binding lectin and burden of infection in children with malignancy: A prospective study. Lancet 2001;358:614-8.
9. Schlapbach LJ, Aebi C, Hansen AG, Hirt A, Jensenius JC, Ammann RA. H-ficolin serum concentration and susceptibility to fever and neutropenia in paediatric cancer patients. Clin Exp Immunol 2009;157:83-9.
10. Schlapbach LJ, Kessler U, Thiel S, et al. M-ficolin in the neonatal period: Associations with need for mechanical ventilation and mortality in premature infants with necrotising enterocolitis. Mol Immunol 2009;46:2597-603.
11. Vollmer-Conna U, Piraino BF, Cameron B, et al.; Dubbo Infection Outcomes Study Group. Cytokine polymorphisms have a synergistic effect on severity of the acute sickness response to infection. Clin Infect Dis 2008;47:1418-25.
12. Gao L, Barnes KC. Recent advances in genetic predisposition to clinical acute lung injury. Am J Physiol Lung Cell Mol Physiol 2009;296: L713-25.
13. Pollack MM, Patel KM, Ruttimann UE. PRISM III: An updated Pediatric Risk of Mortality score. Crit Care Med 1996;24:743-52.
14. Jenkins KJ, Gauvreau K, Newburger JW, Spray TL, Moller JH, Iezzoni LI. Consensus-based method for risk adjustment for surgery for congenital heart disease. J Thorac Cardiovasc Surg 2002;123:110-8.
15. Degn SE, Jensen L, Gál P, et al. Biological variations of MASP-3 and MAp44, two splice products of the MASP1 gene involved in regulation of the complement system. J Immunol Methods 2010;361:37-50.
16. Thiel S, Jensen L, Degn SE, et al. Mannan-binding lectin (MBL)-associated serine protease-1 (MASP-1), a serine protease associated with humoral pattern-recognition molecules: Normal and acute-phase levels in serum and stoichiometry of lectin pathway components. Clin Exp Immunol 2012;169:38-48.
17. Schlapbach LJ, Aebi C, Fisch U, et al. Higher cord blood levels of mannosebinding lectin-associated serine protease-2 in infants with necrotising enterocolitis. Pediatr Res 2008;64:562-6.
18. Sallenbach S, Thiel S, Aebi C, et al. Serum concentrations of lectin-pathway components in healthy neonates, children and adults: Mannan-binding lectin (MBL), M-, L-, and H-ficolin, and MBL-associated serine protease-2 (MASP-2). Pediatr Allergy Immunol 2011;22:424-30.
19. Fisch U, Zehnder A, Hirt A, et al. Mannan-binding lectin (MBL) and MBL-associated serine protease-2 in children with cancer. Swiss Med Wkly 2011;141:w13191.
20. Schlapbach LJ, Thiel S, Aebi C, et al. M-ficolin in children with cancer. Immunobiology 2011;216:633-8.
21. Schlapbach LJ, Aebi C, Otth M, Leibundgut K, Hirt A, Ammann RA. Deficiency of mannose-binding lectin-associated serine protease-2 associated with increased risk of fever and neutropenia in pediatric cancer patients. Pediatr Infect Dis J 2007;26:989-94.
22. Schlapbach LJ, Mattmann M, Thiel S, et al. Differential role of the lectin pathway of complement activation in susceptibility to neonatal sepsis. Clin Infect Dis 2010;51:153-62.
23. Schlapbach LJ, Kjaer TR, Thiel S, et al. M-ficolin concentrations in cord blood are related to circulating phagocytes and to early-onset sepsis. Pediatr Res 2012;71(4 Pt 1):368-74.
24. Frakking FN, Brouwer N, Van Eijkelenburg NK, et al. Low mannose-binding lectin (MBL) levels in neonates with pneumonia and sepsis. Clin Exp Immunol 2007;150:255-62.
25. De Benedetti F, Auriti C, DUrbano LE, et al. Low serum levels of mannose binding lectin are a risk factor for neonatal sepsis. Pediatr Res 2007;61:325-8.
26. St Swierzko A, Cedzynski M, Domzalska-Popadiuk I, et al. Mannanbinding lectin-associated serine protease-2 (MASP-2) in a large cohort of neonates and its clinical associations. Mol Immunol 2009;46: 1696-701.
27. Cortesio CL, Jiang W. Mannan-binding lectin-associated serine protease 3 cleaves synthetic peptides and insulin-like growth factor-binding protein. Arch Biochem Biophys 2006;449:164-70.
28. Degn SE, Jensenius JC, Thiel S. Disease-causing mutations in genes of the complement system. Am J Hum Genet 2011;88:689-705.
29. Sirmaci A, Walsh T, Akay H, et al. MASP1 mutations in patients with facial, umbilical, coccygeal, and auditory findings of Carnevale, Malpuech, OSA, and Michels syndromes. Am J Hum Genet 2010;87:679-86.
30. Rooryck C, Diaz-Font A, Osborn DP, et al. Mutations in lectin complement pathway genes COLEC11 and MASP1 cause 3MC syndrome. Nat Genet 2011;43:197-203.
31. Iwaki D, Kanno K, Takahashi M, Endo Y, Matsushita M, Fujita T. The role of mannose-binding lectin-associated serine protease-3 in activation of the alternative complement pathway. J Immunol 2011;187:3751-8.
32. Degn SE, Jensen L, Hansen AG, et al. Mannan-binding lectin-associated serine protease (MASP)-1 is crucial for lectin pathway activation in human serum, whereas neither MASP-1 nor MASP-3 is required for alternative pathway function. J Immunol 2012;189:3957-69.
33. Lukaszewicz AC, Payen D. The future is predetermined in severe sepsis, so what are the implications Crit Care Med 2010;38(10 Suppl):S512-7.
34. Henckaerts L, Nielsen KR, Steffensen R, et al. Polymorphisms in innate immunity genes predispose to bacteremia and death in the medical intensive care unit. Crit Care Med 2009;37:192-201, e1-3.
35. Thiel S. Complement activating soluble pattern recognition molecules with collagen-like regions, mannan-binding lectin, ficolins and associated proteins. Mol Immunol 2007;44:3875-88.
36. Ytting H, Christensen IJ, Thiel S, et al. Biological variation in circulating levels of mannan-binding lectin (MBL) and MBL-associated serine protease-2 and the influence of age, gender and physical exercise. Scand J Immunol 2007;66:458-64.
37. Krarup A, Sørensen UB, Matsushita M, Jensenius JC, Thiel S. Effect of capsulation of opportunistic pathogenic bacteria on binding of the pattern recognition molecules mannan-binding lectin, L-ficolin, and H-ficolin. Infect Immun 2005;73:1052-60.
38. Wittenborn T, Thiel S, Jensen L, Nielsen HJ, Jensenius JC. Characteristics and biological variations of M-ficolin, a pattern recognition molecule, in plasma. J Innate Immun 2010;2:167-80.
39. Casaer MP, Mesotten D, Hermans G, et al. Early versus late parenteral nutrition in critically ill adults. N Engl J Med 2011;365:506-17.
40. Heinze G, Jüni P. An overview of the objectives of and the approaches to propensity score analyses. Eur Heart J 2011;32:1704-8.
41. Thoemmes F. Propensity score matching in SPSS. ArXiv: 1201.6385 [online], 2012.